New cancer clinical trial: Study on Androgen Receptor and Triple Negative Breast Cancer

Published on: December 25, 2017 at 10:00AM
Conditions:   Breast Cancer Female;   Triple Negative and Androgen Receptor Positive
Interventions:   Drug: Darolutamide;   Drug: Capecitabine
Sponsor:   UNICANCER
Not yet recruiting
http://ift.tt/2DWQIOz